Gainers
VivoSim Labs (NASDAQ:VIVS) shares increased by 82.0% to $0.22 during Thursday's regular session. The market value of their outstanding shares is at $2.4 million.
Marker Therapeutics (NASDAQ:MRKR) sharesread more...
Gainers
VivoSim Labs (NASDAQ:VIVS) shares increased by 82.0% to $0.22 during Thursday's regular session. The market value of their outstanding shares is at $2.4 million.
Marker Therapeutics (NASDAQ:MRKR) sharesread more...
MARKER THERAPEUTICS (MRKR) delivered earnings and revenue surprises of +16.67% and -47.23%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Rigel (RIGL) delivered earnings and revenue surprises of -25.29% and +3.35%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
MARKER THERAPEUTICS (MRKR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Aurinia (AUPH) delivered earnings and revenue surprises of +47.37% and -0.10%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
MARKER THERAPEUTICS (MRKR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
PROKIDNEY CP (PROK) delivered earnings and revenue surprises of -7.69% and +222.86%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?